Cadence Pharmaceuticals (CADX)
Add to Watchlists Create an Alert
6.91
-0.06 -0.86%
NASDAQ
May 24, 5:00PM
BATS Real time
Currency in USD
Cadence Pharmaceuticals Revenue Quarterly YoY Growth:
195.0% for March 31, 2013Cadence Pharmaceuticals Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 195.0% |
| Dec. 31, 2012 | 191.6% |
| Sept. 30, 2012 | 292.5% |
| June 30, 2012 | 60.61% |
| March 31, 2012 | 2187% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
CADX Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Bristol-Myers Squibb | -27.04% |
| Dendreon | -17.64% |
| Targacept | -84.53% |
CADX Revenue Quarterly YoY Growth Rankings
| Overall |
98th percentile 105 of 8009 |
| Sector |
95th percentile 32 of 687 in Healthcare |
| Industry |
93rd percentile 15 of 248 in Biotechnology |
CADX Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | 60.61% | Jun 2012 |
| Maximum | 2187% | Mar 2012 |
| Average | 585.3% |
